Dr Mark Calvin Rowley, MD | |
607 Welch Street, Silverton, OR 97381 | |
(503) 873-7920 | |
(503) 873-7340 |
Full Name | Dr Mark Calvin Rowley |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 607 Welch Street, Silverton, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598771131 | NPI | - | NPPES |
MD18314 | Other | OR | MEDICAL LICENSE |
057005 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD18314 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mark Calvin Rowley, MD Po Box 465, Silverton, OR 97381 Ph: (503) 873-7920 | Dr Mark Calvin Rowley, MD 607 Welch Street, Silverton, OR 97381 Ph: (503) 873-7920 |
News Archive
Researchers at Children's Hospital of Philadelphia have developed a novel treatment for sepsis - one of the leading causes of hospital death - that enhances the body's bacteria-capturing neutrophil extracellular traps so that they more effectively capture infectious bacteria, resist degradation, and improve sepsis outcomes and survival.
A joint research effort by the Hospital and the Instituto de Investigación Germans Trias i Pujol is characterizing and studying a new cohort of cardiogenic shock patients to predict the risk of having this heart attack-derived complication which, while infrequent, sometimes presents a fatal outcome.
The Washington Post compares how Medicare fares under the health law versus under the Ryan plan, while NBC questions whether the GOP effort to hammer President Obama for reducing Medicare spending to pay for the health overhaul will work - especially since GOP budget proposals make the same cuts.
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today the online publication of the results from the CLARITY Phase III trial using Cladribine Tablets (EMD Serono's proprietary investigational oral formulation of cladribine) in The New England Journal of Medicine. The CLARITY study was a two-year (96-week), randomized, double-blind, placebo-controlled Phase III trial of Cladribine Tablets in 1,326 people with relapsing-remitting multiple sclerosis (MS).
› Verified 9 days ago
John P Yang, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Glenn Ira Bernstein, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Brooke Denise Renard, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Denis Jon Dalisky, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Dr. Amy Nicole Zastrow, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-364-3787 | |
Dr. Barbara Linn Keller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 |